Zobrazeno 1 - 10
of 85
pro vyhledávání: '"O, Akinyanju"'
Autor:
Aldo Morrone, Manuela Testi, T. Thompson Wakama, Jose Manuel Nunes, Alicia Sanchez-Mazas, Olufemi O Akinyanju, Guido Lucarelli, Marco Andreani, Antonella Isgrò, Mariarosa Battarra
Publikováno v:
Tissue Antigens. 86:285-292
The simultaneous typing of five-HLA loci at high resolution and the availability of pedigree data allowed us to characterize extended five-locus phased haplotypes in 124 Nigerian families and to compare the observed frequencies with those expected by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc57de9ef2cb8c389ff36bd38277c0ae
https://doi.org/10.1111/tan.12642
https://doi.org/10.1111/tan.12642
Autor:
G De Angelis, Katia Paciaroni, Manuela Testi, Marco Andreani, Cristiano Gallucci, Guido Lucarelli, D Armiento, Javid Gaziev, C Alfieri, L Cardarelli, Michela Ribersani, T. Thompson Wakama, Anthony A. Amato, Pietro Sodani, Olufemi O Akinyanju, Antonella Isgrò, Marco Marziali
Publikováno v:
Bone Marrow Transplantation. 49:1376-1381
Sickle cell anemia (SCA) remains associated with high risks of morbidity and early death. Allogeneic hematopoietic SCT (HSCT) is the only curative treatment for SCA. We report our experience with transplantation in a group of patients with the non-Bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b3547803b1e6e25a2e09ad329920f72
https://doi.org/10.1038/bmt.2014.167
https://doi.org/10.1038/bmt.2014.167
Autor:
Patrick H. O’Reilly, A Olujohungbe, A. Akenova, J. Morris, O. Akinyanju, Adebanji Adeyoju, K. Cinkotai, D. Bareford, A. Yardumian
Publikováno v:
BJU International. 90:898-902
Objective To define the incidence, risk factors and complications of priapism in a large population of patients with sickle-cell anaemia in five centres in the UK and Nigeria, as priapism is common among these patients, but the precise characteristic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5776789a4b3028d098bd8314069d0301
https://doi.org/10.1046/j.1464-410x.2002.03022.x
https://doi.org/10.1046/j.1464-410x.2002.03022.x
Autor:
A. A. Raji, B. S. Audu, M. O. Balogun, I. J. Emodi, C. Wambebe, C. Nwokolo, C. M. Chukwuani, O. Akinyanju
Publikováno v:
Clinical Drug Investigation. 21:537-544
Objective To compare the efficacy and tolerability of mefloquine and proguanil in malaria prophylaxis in sickle cell anaemia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f70d89ec528fba076d1153efb9fc256a
https://doi.org/10.2165/00044011-200121080-00002
https://doi.org/10.2165/00044011-200121080-00002
Autor:
M. O. O. Ibidapo, O. O. Akinyanju
Publikováno v:
Clinical & Laboratory Haematology. 22:151-155
The pattern of acute illness was determined in 102 adolescents and adults with sickle cell anaemia who presented to the emergency unit of a Lagos hospital. The patients had a mean age of 20.5 years (SD 13.1) and a male-female ratio of 1.5. The sympto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56f62fdc62af5372a75bc5a7093562d3
https://doi.org/10.1046/j.1365-2257.2000.00292.x
https://doi.org/10.1046/j.1365-2257.2000.00292.x
Publikováno v:
Prenatal Diagnosis. 19:299-304
We introduced prenatal diagnosis of SCD in Nigeria in order to meet a rising demand. Our approach and experience are documented as a guide to others in countries with similar problems. A cost-recovery fee charged only to sustain the service predictab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e867ca03616466e0969a447f7173f5b
https://doi.org/10.1002/(sici)1097-0223(199904)19:4<299::aid-pd503>3.0.co
https://doi.org/10.1002/(sici)1097-0223(199904)19:4<299::aid-pd503>3.0.co
Autor:
Oluwole O. Famuyiwa, Olu O. Akinyanju
Publikováno v:
International Journal of Social Psychiatry. 44:170-180
This study examines the burden on the families of children with sickle cell anaemia in a naturalistic setting. Compared with a matched group of epileptics (N=76) families of sickle cell anaemia victims aged 12 years and below (N = 85) suffer greater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efbf303f81499659d488debae7ea8801
https://doi.org/10.1177/002076409804400303
https://doi.org/10.1177/002076409804400303
Autor:
Pietro Sodani, Marco Andreani, Michela Ribersani, Guido Lucarelli, Cristiano Gallucci, Cecilia Alfieri, Manuela Testi, Festus Olusola Olowoselu, Olufemi O Akinyanju, T. Thompson Wakama, Javid Gaziev, Katia Paciaroni, Antonella Isgrò, Marco Marziali, Gioia De Angelis
Publikováno v:
Blood. 126:4598-4598
Introduction: Sickle cell anemia (SCA) remains associated with high risks of morbidity and early death. Children with SCA are at high risk for ischemic stroke and transient ischemic attacks, secondary to intracranial arteriopathy involving carotid an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67ccab31e4feb359e37bdb57b1839f35
https://doi.org/10.1182/blood.v126.23.4598.4598
https://doi.org/10.1182/blood.v126.23.4598.4598
Autor:
Michela Ribersani, Marco Marziali, Olufemi O Akinyanju, T. Thompson Wakama, Katia Paciaroni, Adewumi Adediran, Javid Gaziev, Gioia De Angelis, Cristiano Gallucci, Festus Olusola Olowoselu, Cecilia Alfieri, Guido Lucarelli, Pietro Sodani, Antonella Isgrò, Andrea Roveda
Publikováno v:
Nigerian Medical Journal : Journal of the Nigeria Medical Association
Background: Sickle cell anaemia (SCA) remains associated with high risks of morbidity and early death. Children with SCA are at high risk for ischaemic stroke and transient ischaemic attacks, secondary to intracranial arteriopathy involving carotid a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2beccaef230f77aa93b26a9e37521d0c
https://doi.org/10.4103/0300-1652.160355
https://doi.org/10.4103/0300-1652.160355
Publikováno v:
Nigerian Quarterly Journal of Hospital Medicine; Vol 9, No 4 (1999); 256-259
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1ad262a416692b2ce2b64c685a566cc
https://www.ajol.info/index.php/nqjhm/article/view/12396
https://www.ajol.info/index.php/nqjhm/article/view/12396